GL
Geulah Livshits Chardan Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Krystal Biotech
KRYS
$4.35B
| $150.27 | $216 |
44%
upside
| Buy | 16 days ago |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $3.28 | $11 |
235%
upside
| Buy | 17 days ago |
|
3
Lexeo Therapeutics
LXEO
$271M
| $5.02 | $15 |
199%
upside
| Buy | 22 days ago |
|
|
PVLA
4
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $55.68 | $60 |
8%
upside
| Buy | 23 days ago |
|
5
Solid Biosciences
SLDB
$428M
| $5.50 | $15 |
173%
upside
| Buy | 23 days ago |
|
6
Taysha Gene Therapies
TSHA
$917M
| $3.36 | $10 |
198%
upside
| Buy | 25 days ago |
|
7
4D Molecular Therapeutics
FDMT
$340M
| $7.27 | $25 |
244%
upside
| Buy | 26 days ago |
|
8
Intellia Therapeutics
NTLA
$1.29B
| $12.06 | $60 |
398%
upside
| Buy | 27 days ago |
|
9
Prime Medicine
PRME
$663M
| $3.72 | $10 |
169%
upside
| Buy | 29 days ago |
|
10
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $20 |
703%
upside
| Buy | 1 month ago |
|
11
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $82 |
49%
upside
| Buy | 1 month ago |
|
12
MeiraGTx Holdings
MGTX
$619M
| $7.69 | $41 |
433%
upside
| Buy | 2 years ago |
|
13
Immatics
IMTX
$761M
| $6.26 | $25 |
299%
upside
| Buy | 2 years ago |
|
14
Moderna
MRNA
$9.78B
| $25.14 | $208 |
727%
upside
| Neutral | 2 years ago |
|
15
Regenxbio
RGNX
$490M
| $9.71 | $90 |
827%
upside
| Buy | 3 years ago |
|
16
Immunome
IMNM
$916M
| $10.52 | $18 |
71%
upside
| Buy | 4 years ago |
|